Comparable stake leader
BlackRock, Inc.
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0000784199.
Comparable stake leader
BlackRock, Inc.
Disclosed value leader
BlackRock, Inc.
Comparable rows
6/50
Latest evidence
30 Sep 2026
Ownership snapshot
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Quick read
6 of 50 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BlackRock, Inc. |
13D/G
|
15%
Reported 13D/G
· 30 Sep 2026
|
$163,374,747
7,159,279 shares
|
+$26,973,582 | 30 Sep 2026 |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. |
13F
13D/G
Company
|
6.5%
Reported 13D/G
· 30 Jun 2026
|
$72,269,320
3,166,929 shares
|
— | 30 Sep 2026 |
| MORGAN STANLEY |
13D/G
13F
Company
|
4.4%
Reported 13D/G
· 30 Sep 2025
|
$87,854,442
2,074,975 shares
|
$0 | 30 Sep 2025 |
| PERCEPTIVE ADVISORS LLC |
13D/G
13F
Company
|
4.3%
Reported 13D/G
· 30 Sep 2025
|
$85,526,800
2,020,000 shares
|
$0 | 30 Sep 2025 |
| Juniper Investment Company, LLC |
13D/G
13F
Company
|
4%
Reported 13D/G
· 08 Aug 2025
|
$56,474,160
1,864,449 shares
|
$0 | 08 Aug 2025 |
| FMR LLC |
13D/G
|
4%
Reported 13D/G
· 30 Jun 2026
|
$44,119,202
1,963,471 shares
|
-$7,292,841 | 30 Jun 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC |
13F
Company
|
—
denominator unverified
|
$47,073,803
2,062,831 shares
|
— | 30 Sep 2026 |
| STATE STREET CORP |
13F
Company
|
—
denominator unverified
|
$45,484,527
1,993,187 shares
|
— | 30 Sep 2026 |
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Net insider flow leans to selling over the last 12 months. Net value: -$14,866,726.
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 19,483 | $0 | $502,993 | -$502,993 |
| 3-6 | 0 | 116,309 | $0 | $3,003,422 | -$3,003,422 |
| 6-9 | 0 | 133,043 | $0 | $4,977,133 | -$4,977,133 |
| 9-12 | 0 | 141,381 | $0 | $6,383,178 | -$6,383,178 |
Reporting owners
Showing 1-20 of 24 reporting-owner rows connected to ARTIVION, INC.. Open a relationship link for the CIK-to-CIK filing trail.
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| James P. Mackin | President & CEO | $25,401,497 | -$7,369,298 | -22% | Filing P/S | 19 Aug 2026 |
| John E. Davis | Chief Commercial Officer | $8,718,381 | -$720,042 | -7.6% | Filing P/S | 02 Mar 2026 |
| David Ashley Lee | Executive VP, COO & CFO | $6,655,986 | Mixed | 01 Mar 2023 | ||
| Lance A. Berry | EVP, COO, CFO & Treasurer | $5,998,487 | -$803,205 | -12% | Filing P/S | 14 Aug 2026 |
| Daniel J. Bevevino | Director | $5,772,666 | Mixed | 18 May 2026 | ||
| Thomas F. Ackerman | Director | $5,766,624 | Mixed | 18 May 2026 | ||
| Amy Horton | VP, Chief Accounting Officer | $5,254,132 | -$356,183 | -6.3% | Filing P/S | 02 Mar 2026 |
| Jean F. Holloway | SVP, General Counsel | $5,245,521 | -$1,103,210 | -17% | Filing P/S | 12 Aug 2026 |
| Jon W. Salveson | Director | $5,032,173 | Mixed | 18 May 2026 | ||
| James Bullock | Director | $2,791,286 | Mixed | 18 May 2026 | ||
| Marshall S. Stanton | SVP, Clinical & MD Affair | $2,270,200 | -$3,083,470 | -58% | Filing P/S | 02 Mar 2026 |
| Jeffrey H. Burbank | Director | $2,247,442 | Mixed | 18 May 2026 | ||
| Ronald D. McCall | Director | $2,191,824 | Mixed | 25 Aug 2021 | ||
| Marna P. Borgstrom | Director | $2,075,035 | Mixed | 18 May 2026 | ||
| Harvey Morgan | Director | $1,747,980 | Mixed | 30 Aug 2021 | ||
| Anthony B. Semedo | Director | $1,741,646 | Mixed | 02 Jun 2026 | ||
| Elizabeth A. Hoff | Director | $1,273,094 | Mixed | 18 May 2026 | ||
| Andrew M. Green | SVP, Regulatory and Quality | $1,002,795 | -$1,431,318 | -59% | Filing P/S | 10 Sep 2026 |
| Rochelle L. Maney | VP, Quality | $871,883 | Filing P/S | 01 Mar 2024 | ||
| Matthew A. Getz | VP, Human Resources | $863,527 | Filing P/S | 16 Aug 2024 |
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Andrew M. Green | AORT | Common Stock | Sale | -22.2% | -$286,656 | $24.97 | -11,480 | 40,160 | 10 Sep 2026 | Direct |
| Andrew M. Green | AORT | Common Stock | Sale | -2.81% | -$38,842 | $26.02 | -1,493 | 51,640 | 03 Sep 2026 | Direct |
| Andrew M. Green | AORT | Common Stock | Sale | -10.9% | -$177,495 | $27.26 | -6,510 | 53,133 | 02 Sep 2026 | Direct |
| James P. Mackin | AORT | Common Stock | Sale | -7.39% | -$2,026,850 | $28.96 | -70,000 | 877,275 | 19 Aug 2026 | Direct |
| Andrew M. Green | AORT | Common Stock | Sale | -1.02% | -$17,586 | $28.55 | -616 | 59,643 | 14 Aug 2026 | Direct |
| Lance A. Berry | AORT | Common Stock | Sale | -0.34% | -$20,413 | $28.55 | -715 | 210,112 | 14 Aug 2026 | Direct |
| Jean F. Holloway | AORT | Common Stock | Sale | -0.53% | -$27,835 | $28.49 | -977 | 184,118 | 12 Aug 2026 | Direct |
| Andrew M. Green | AORT | Common Stock | Sale | -42.2% | -$910,739 | $20.70 | -44,001 | 60,259 | 11 Jun 2026 | Direct |
| Andrew M. Green | AORT | Common Stock | Options Exercise | 95.1% | 44,001 | 90,259 | 11 Jun 2026 | Direct | ||
| Andrew M. Green | AORT | Stock Options (Right to buy) | Options Exercise | -100% | -44,001 | 0 | 11 Jun 2026 | Direct | ||
| Anthony B. Semedo | AORT | Common Stock | Other | 6,325 | 6,325 | 02 Jun 2026 | By the Stacie Nelson and Anthony Semedo Living Trust | |||
| Anthony B. Semedo | AORT | Common Stock | Other | -13.5% | -6,325 | 40,635 | 02 Jun 2026 | Direct | ||
| Marna P. Borgstrom | AORT | Common Stock | Award | 15.4% | 7,576 | 56,664 | 18 May 2026 | Direct | ||
| Anthony B. Semedo | AORT | Common Stock | Award | 19.2% | 7,576 | 46,960 | 18 May 2026 | Direct | ||
| Jon W. Salveson | AORT | Common Stock | Award | 5.83% | 7,576 | 137,416 | 18 May 2026 | Direct | ||
| Elizabeth A. Hoff | AORT | Common Stock | Award | 27.9% | 7,576 | 34,765 | 18 May 2026 | Direct | ||
| Jeffrey H. Burbank | AORT | Common Stock | Award | 14.1% | 7,576 | 61,372 | 18 May 2026 | Direct | ||
| James Bullock | AORT | Common Stock | Award | 11% | 7,576 | 76,223 | 18 May 2026 | Direct | ||
| Daniel J. Bevevino | AORT | Common Stock | Award | 5.05% | 7,576 | 157,637 | 18 May 2026 | Direct | ||
| Thomas F. Ackerman | AORT | Common Stock | Award | 5.05% | 7,576 | 157,472 | 18 May 2026 | Direct | ||
| Marna P. Borgstrom | AORT | Common Stock | Award | 16% | 7,850 | 56,938 | 14 May 2026 | Direct | ||
| Jean F. Holloway | AORT | Common Stock | Sale | -4.62% | -$340,556 | $38.00 | -8,962 | 185,095 | 04 Mar 2026 | Direct |
| Amy Horton | AORT | Common Stock | Sale | -0.64% | -$34,036 | $37.78 | -901 | 139,088 | 03 Mar 2026 | Direct |
| Jean F. Holloway | AORT | Common Stock | Sale | -1.94% | -$145,172 | $37.78 | -3,843 | 194,057 | 03 Mar 2026 | Direct |
| Marshall S. Stanton | AORT | Common Stock | Sale | -3.45% | -$81,180 | $37.78 | -2,149 | 60,097 | 03 Mar 2026 | Direct |
| John E. Davis | AORT | Common Stock | Sale | -1.94% | -$172,748 | $37.78 | -4,573 | 230,794 | 03 Mar 2026 | Direct |
| Lance A. Berry | AORT | Common Stock | Sale | -2.91% | -$238,591 | $37.78 | -6,316 | 210,827 | 03 Mar 2026 | Direct |
| James P. Mackin | AORT | Common Stock | Sale | -1.85% | -$675,692 | $37.78 | -17,887 | 947,275 | 03 Mar 2026 | Direct |
| Amy Horton | AORT | Common Stock | Award | 5.64% | 7,475 | 139,989 | 02 Mar 2026 | Direct | ||
| Jean F. Holloway | AORT | Common Stock | Award | 16.3% | 27,795 | 197,900 | 02 Mar 2026 | Direct | ||
| Marshall S. Stanton | AORT | Common Stock | Award | 54% | 21,838 | 62,246 | 02 Mar 2026 | Direct | ||
| John E. Davis | AORT | Common Stock | Award | 14% | 28,845 | 235,367 | 02 Mar 2026 | Direct | ||
| Lance A. Berry | AORT | Common Stock | Award | 23.2% | 40,874 | 217,143 | 02 Mar 2026 | Direct | ||
| James P. Mackin | AORT | Common Stock | Award | 13.8% | 116,948 | 965,162 | 02 Mar 2026 | Direct | ||
| Amy Horton | AORT | Common Stock | Sale | -0.48% | -$24,374 | $38.02 | -641 | 132,514 | 02 Mar 2026 | Direct |
| Marshall S. Stanton | AORT | Common Stock | Sale | -3.61% | -$57,532 | $38.02 | -1,513 | 40,408 | 02 Mar 2026 | Direct |
| James P. Mackin | AORT | Common Stock | Sale | -1.73% | -$566,989 | $38.02 | -14,911 | 848,214 | 02 Mar 2026 | Direct |
| Jean F. Holloway | AORT | Common Stock | Sale | -1.27% | -$83,008 | $38.02 | -2,183 | 170,105 | 02 Mar 2026 | Direct |
| Lance A. Berry | AORT | Common Stock | Sale | -2.85% | -$196,893 | $38.02 | -5,178 | 176,269 | 02 Mar 2026 | Direct |
| John E. Davis | AORT | Common Stock | Sale | -1.33% | -$105,861 | $38.02 | -2,784 | 206,522 | 02 Mar 2026 | Direct |
| Amy Horton | AORT | Common Stock | Award | 4.44% | 5,658 | 133,155 | 24 Feb 2026 | Direct | ||
| Amy Horton | AORT | Common Stock | Sale | -0.65% | -$29,625 | $35.69 | -830 | 127,497 | 24 Feb 2026 | Direct |
| Marshall S. Stanton | AORT | Common Stock | Sale | -2.92% | -$44,937 | $35.69 | -1,259 | 41,921 | 24 Feb 2026 | Direct |
| Jean F. Holloway | AORT | Common Stock | Award | 13.2% | 20,085 | 172,288 | 24 Feb 2026 | Direct | ||
| Jean F. Holloway | AORT | Common Stock | Sale | -1.08% | -$59,536 | $35.69 | -1,668 | 152,203 | 24 Feb 2026 | Direct |
| James P. Mackin | AORT | Common Stock | Award | 12.7% | 97,030 | 863,125 | 24 Feb 2026 | Direct | ||
| James P. Mackin | AORT | Common Stock | Sale | -1.79% | -$497,418 | $35.69 | -13,936 | 766,095 | 24 Feb 2026 | Direct |
| Lance A. Berry | AORT | Common Stock | Award | 26% | 37,482 | 181,447 | 24 Feb 2026 | Direct | ||
| Lance A. Berry | AORT | Common Stock | Sale | -3.02% | -$160,083 | $35.69 | -4,485 | 143,965 | 24 Feb 2026 | Direct |
| John E. Davis | AORT | Common Stock | Award | 10.8% | 20,438 | 209,306 | 24 Feb 2026 | Direct |